HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2-ethyl-2-oxazoline

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - 2-ethyl-2-oxazoline: 1

Experts

1.	Gao, Yajie: 1 article (04/2015)
2.	Li, Jinwen: 1 article (04/2015)
3.	Li, Xinru: 1 article (04/2015)
4.	Liu, Yan: 1 article (04/2015)
5.	Ma, Shujin: 1 article (04/2015)
6.	Wang, Dishi: 1 article (04/2015)
7.	Zhang, Chao: 1 article (04/2015)
8.	Zhao, Lei: 1 article (04/2015)
9.	Zhao, Yong: 1 article (04/2015)
10.	Zhou, Yanxia: 1 article (04/2015)

Related Diseases

1.

Neoplasms (Cancer)

04/01/2015 - "To ensure that two drugs can be co-delivered to the tumor region and quickly released in tumor cells, tumor-targeted and pH-sensitive polymeric micelles were designed and prepared by combining cationic ring-opening polymerization of 2-ethyl-2-oxazoline (EOz) with anionic ring-opening polymerization of D,L-lactide (LA), and then encapsulating doxorubicin (DOX) and D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS1000) into the micelles self-assembled by poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) (PEOz-PLA) and DSPE-PEG-folate. "

Related Drugs and Biologics

1.	Micelles
2.	Doxorubicin (Adriamycin)
3.	poly(ethylene glycol)-folate
4.	dilactide
5.	1,2-distearoylphosphatidylethanolamine (DSPE)
6.	tocophersolan